Menu
IASIS Technologies Corporation Healing Through Neurofeedback
IASIS Technologies Corporation (IASIS Tech) developed IASIS Micro Current Neurofeedback (MCN), a form of LIP-tES: Low-Intensity Pulses using transcranial Electrical Stimulation. While our primary focus is in the arena of supporting mental health providers with solutions for their patients, it also serves Military & First Responders. It has been observed to be helpful for Autism Spectrum Disorders, ADD, ADHD, OCD, Anxiety, Post Stroke, Epilepsy, m-TBI (mild to moderate traumatic brain injury), certain forms of chronic pain, headache, migraine, insomnia, brain fog, memory disorders, Lyme, improved executive function naming only a few. IASIS is presently engaged in developing a Home Based companion device to the Clinical Model of IASIS MCN.
For more information on ITI or the IASIS MCN device, please contact us at (951) 894-1045 and feel the power of neurofeedback therapy in your practice.
IASIS Technologies History, Milestones & Community
MISSION: To achieve global relation and well-being for all.
IASIS Technologies Corporation was Founded in 2010 by Laura & Barry Bruder. Barry had been certified as a LENS Provider (LENS is Low Energy Neurofeedback System) and found it very helpful. While he valued his experience working as a LENS Provider, he was convinced there was a more elegant means of administering neurofeedback.
Such notable institutions employ IASIS Neurofeedback as St. Joseph’s Medical Center in Houston in the Matthews Hope Foundation’s Medical Detox Center.
As Bruder often shares, ‘Without science, one is just a nice person with a nice idea.’ In 2017, the first research study, a UC San Diego & VA IRB-approved study, was published in the Brain Injury Journal. Additional studies are presently underway with UC San Diego and the VA in year 3 of a 4-year study and three other studies with the University of Texas at Tyler: Anxiety, depression and Substance Abuse Disorder focusing on Opioid abuse.
Meet the IASIS Tech Advisory Board
Barry Bruder
CEO & Co-Founder
Larry Wedekind, ICP
IASIS Board Chair
Theresa Horab
RN, ICT, Director of Provider Care
Jennifer O'Neal, LMSW, ICP
Clinical Advisor
Ryan McWhorter, MD, ICP
Clinical Director
Hai Jin Kim, MD, ICP
Clinical Advisor
Brett Fuller, DC, CCSP, FIAMA, ICP
Clinical Advisor
Fara Murata, LCSW, ICP
Clinical Advisor
William A. Chatfield
Strategy Advisor
Hugh Bruder, PMD, ICP
Fire Rescue Advisor
David Carrasquillo, ICP
Law Enforcement Advisor
Michael Brown, PhD, ICP
Clinical Advisor
Miche Lamarche, LAc, ICP, ICT
Clinical Advisor
Susan Rohr, BSN RN, ICP
Clinical Advisor
Simon Yu, MD, ICP
Clinical Advisor
Rajean Moseley-LaRue, PA-C, ICP
Clinical Advisor
Germaine Hawkins, DO, ICP
Clinical Advisor
Jeremy Lelek, Ph.D., LPC-S, ICP
Clinical Advisor
Anne Marie Biancalana, RN, ICP
Clinical Advisor
Dudley Chewning, LMFT, ICP
Clinical Advisor
Clyde McMorris, MD, ICP
Clinical Advisor
Wally Taylor, MD, ICP
Clinical Advisor
Jason Gourlas, MPAS, PA-C, ICP
Clinical Advisor - Curriculum
Val Gourlas, ICP-P
Clinical Advisor - Curriculum
Carrie Vaccarella, M.A., LPC, ICP
Clinical AdvisorIASIS Micro Current Neurofeedback FAQs
Yes, extremely safe. There has not been a single reported case of someone being worse off from being treated with MCN Micro Current Neurofeedback.
In the first few MCN Micro Current Neurofeedback sessions, a client sometimes experiences temporary fatigue, “light headedness” or a feeling of being “revved up.” Mild headaches also occasionally occur. These symptoms are always temporary, and typically last only a few minutes to a few hours.
MCN Micro Current Neurofeedback is very effective in many areas, including:
Post Traumatic Stress Disorder – MCN Micro Current Neurofeedback is exceptionally effective at reducing Post Traumatic Stress Disorder (PTSD) and other forms anxiety. Ninety percent of clients begin to experience improvement in the first or second session. MCN Micro Current Neurofeedback also improves resilience, the ability to handle stress, and helps create a sense of calm in difficult situations.
Traumatic Brain Injury (TBI) – In mild and moderate TBI, clarity, concentration, memory, multi-tasking and energy consistently and rapidly improve.
ADD/ADHD – MCN Micro Current Neurofeedback decreases impulsivity, distractibility and hyperactivity. The world becomes easier to navigate. Life becomes less of a struggle.
Substance Abuse – Because MCN Micro Current Neurofeedback is so effective at treating anxiety, depression and poor impulse control, it can be tremendously helpful for people withdrawing from and staying away from addictive substances. MCN Neurofeedback is now being used at many recovery centers.
Most people notice initial changes within three sessions, occasionally a few more. The average number of sessions varies depending on the acuity of one’s condition. Once treatment has been completed, additional sessions are usually not necessary. Occasionally individuals may require a “booster.”
The success rate is staggering. Over 85% of clients claim by their own assessment that they experience significant, often dramatic, benefits. With traumatic brain injury, clarity begins to return, headaches and migraines diminish. The “fog” begins to lift and cognitive function begins to return. In PTSD, anxiety starts to abate, panic attacks stop, and sleep improves. And the changes are enduring. Once enough sessions have been completed, assisting the recipient to get closer, treatment is usually done.
No. Medication does not diminish the effectiveness of IASIS MCN Micro Current Neurofeedback. There is no need to stop or reduce your medication, which should only be done in conjunction with your healthcare provider once MCN treatment is complete.
MCN uses a very low power (3 pico or 3 trillionths of a watt) electromagnetic field to carry feedback to the person receiving it. The feedback travels down the same wires carrying the brain waves to the amplifier and computer.
Although the MCN signal is weak, it produces a measurable change in the brainwaves without conscious effort from the individual receiving the feedback. This feedback frequency correlates with the dominant brainwave frequency. When exposed to this feedback frequency, the EEG amplitude distribution changes in power. The result is a changed brainwave state and much greater ability for the brain and nervous system to regulate itself.
MCN is a direct feedback, imperceptible to the client, and requiring no conscious effort. Although, like many pharmaceuticals, MCN is not yet completely understood, at the very least the sympathetic and parasympathetic nervous systems are profoundly influenced as is the central nervous systems. Brain chemistry is affected in ways that still need to be elucidated.
In traditional neurofeedback, information from your brainwaves is transmitted to a computer screen. Clients attempt to train their brainwaves by mentally manipulating events on the screen. No signal is transmitted back to the brain. This kind of neurofeedback typically requires 40+ sessions, with a typical session lasting 45 minutes to an hour.
With MCN Micro Current Neurofeedback clients don’t do anything other than sit still for a few moments. A brief, tiny signal transmitted feeding back to the brain does all the work. And unlike traditional neurofeedback clients, MCN Micro Current Neurofeedback clients generally notice changes either immediately or within the first few sessions. Fast action, limited number of sessions, and the ease and simplicity of treatment all distinguish MCN Micro Current Neurofeedback from traditional neurofeedback.
Practitioners have used earlier and similar versions of MCN Micro Current Neurofeedback for over 15 years. MCN Micro Current Neurofeedback is not experimental. Over 75,000 patients have been treated with technologies similar in principle to IASIS MCN Micro Current Neurofeedback.
Only frozen, stuck patterns are affected. Healthy, functional brainwave patterns are flexible and resilient. When there is a tiny fluctuation they automatically spring back to their healthy patterns.
No. IASIS MCN is only to be administered to patients by trained doctors and clinicians. It is not intended for home use.
DISCLAIMER: This website does not contain medical advice. IASIS Neurofeedback, rather, the IASIS MCN device is indicated for relaxation training and muscle reeducation and prescription use consistent with 21 C.F.R. section 882.5050.” A biofeedback device is an instrument that provides a visual or auditory signal corresponding to the status of one or more of a patient’s physiological parameters (e.g., brain alpha wave activity, muscle activity, skin temperature, etc.) so that the patient can control voluntarily these physiological parameters; and a prescription battery powered device that is indicated for relaxation training and muscle reeducation and prescription use. The information, including but not limited to text, videos, images, and other material contained on this website is for informational purposes only. The purpose of this website is to promote broad consumer understanding and knowledge about IASIS Neurofeedback. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you believe you have a medical condition, please first, always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. Never self-medicate or choose to discontinue taking medicine without discussing your medical care with your doctor.
